ACXP · Acurx Pharmaceuticals, Inc.

Acurx Pharmaceuticals Inc Is A Late-Stage Biopharmaceutical Company Focused On Developing A New Class Of Small-Molecule Antibiotics For Difficult-To-Treat Bacterial Infections. Its Approach Is To Develop Antibiotic Candidates With A Gram-Positive Selective Spectrum (Gpss) That Block The Active Site Of The Gram-Positive Specific Bacterial Enzyme Deoxyribonucleic Acid (Dna) Polymerase Iiic (Pol Iiic), Inhibiting Dna Replication And Gram-Positive Bacterial Cell Death. Its Research And Development Pipeline Includes Antibiotic Product Candidates Targeting Gram-Positive Bacteria, Including Clostridioides Difficile, Methicillin-Resistant Staphylococcus Aureus, Vancomycin-Resistant Enterococcus, And Drug-Resistant Streptococcus Pneumoniae And B. Anthracis. It Operates In A Single Segment.